Lentsch Family Endowed Chair for Valve and Structural Heart
Banner Health
Scottsdale, Arizona, United States
Dr. Paul Sorajja is an interventional cardiologist at Banner Health in Phoenix, AZ. He received his M.D. from Mayo Medical School, and completed his traing at Mayo. Dr. Sorajja joined the Mayo Clinic staff in 2006, achieving the rank of Professor of Medicine in 2012. In 2013, Dr. Sorajja joined the Minneapolis Heart Institute. In 2025, Dr Sorajja joined Banner Health. Dr. Sorajja's focus is on catheter-based therapy of valvular and structural heart disease. He was part of the team that performed the first TMVR in the U.S. in 2015. Dr. Sorajja has served or serves as the global or national PI for many clinical trials. He is known especially for performing many FIH therapies including the first TriClip (2017), MitraClip laceration and TMVR (2018), dedicated TMVR in severe MAC (2016), vDyne (2021), MitraClip for HCM (2016). Dr. Sorajja has published over 500 manuscripts and book chapters.
Disclosure(s): Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing); Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing)
Anatomy, Indications and Outcomes for Tricuspid TEER for Incomplete Coaptation
Saturday, March 7, 2026
8:10 AM - 8:20 AM EST
Panel Discussion | How to Select Candidates for Tricuspid Repair/Replacement
Saturday, March 7, 2026
9:20 AM - 9:40 AM EST
Live Case Broadcasting From Piedmont | Atlanta, Georgia
Saturday, March 7, 2026
9:40 AM - 10:25 AM EST
Saturday, March 7, 2026
11:05 AM - 11:15 AM EST
Panel Discussion | Are We Ready for Repair and Replacement of Tricuspid Disease?
Saturday, March 7, 2026
11:25 AM - 11:45 AM EST
TMVR Devices | AltaValve Update
Sunday, March 8, 2026
3:49 PM - 3:57 PM EST
Panel Discussion | Percutaneous Mitral Valve Replacement | Preliminary Data Reports – Technologies
Sunday, March 8, 2026
4:05 PM - 4:25 PM EST